Our Investment Focus

As a strategic fund, SGBV invests directly in private early-stage biotech and healthcare innovation companies with promising new products or technologies that align with Sanofi’s current and future areas of business interest.

Current core areas of strategic interest include:

  • rare diseases,
  • oncology,
  • vaccines,
  • immune-mediated diseases,
  • diabetes,
  • cardiovascular disease,
  • breakthrough therapies in other core areas of interest,
  • integrated health solutions.